Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helianthus | 1 | 2024 | 11 | 0.920 |
Why?
|
| Anti-Allergic Agents | 1 | 2021 | 153 | 0.670 |
Why?
|
| Hypersensitivity | 1 | 2024 | 1171 | 0.470 |
Why?
|
| Sesamum | 1 | 2013 | 20 | 0.450 |
Why?
|
| Nut Hypersensitivity | 1 | 2013 | 33 | 0.440 |
Why?
|
| Peanut Hypersensitivity | 1 | 2013 | 219 | 0.350 |
Why?
|
| beta-Lactams | 2 | 2019 | 155 | 0.270 |
Why?
|
| Drug Hypersensitivity | 3 | 2020 | 917 | 0.260 |
Why?
|
| Seeds | 1 | 2024 | 122 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 2518 | 0.180 |
Why?
|
| Desensitization, Immunologic | 2 | 2021 | 556 | 0.150 |
Why?
|
| Skin Tests | 2 | 2017 | 637 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.100 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2013 | 302 | 0.100 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 547 | 0.100 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2013 | 363 | 0.100 |
Why?
|
| Meningomyelocele | 1 | 2012 | 171 | 0.090 |
Why?
|
| Gelatin | 1 | 2012 | 220 | 0.090 |
Why?
|
| Hemostatics | 1 | 2012 | 241 | 0.080 |
Why?
|
| Bronchi | 1 | 2013 | 845 | 0.080 |
Why?
|
| Progesterone | 1 | 2013 | 742 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4652 | 0.080 |
Why?
|
| Scoliosis | 1 | 2012 | 741 | 0.060 |
Why?
|
| Anaphylaxis | 1 | 2012 | 757 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2898 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 2007 | 535 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2244 | 0.050 |
Why?
|
| Sirtuins | 1 | 2006 | 320 | 0.050 |
Why?
|
| Spinal Fusion | 1 | 2012 | 1286 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2006 | 709 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2006 | 604 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 3080 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7406 | 0.040 |
Why?
|
| Cephalosporins | 1 | 2019 | 198 | 0.040 |
Why?
|
| Humans | 12 | 2024 | 761596 | 0.040 |
Why?
|
| Apoptosis | 1 | 2013 | 9490 | 0.030 |
Why?
|
| Inpatients | 2 | 2019 | 2548 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7859 | 0.030 |
Why?
|
| Penicillins | 1 | 2019 | 402 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2015 | 173 | 0.030 |
Why?
|
| Asthma | 1 | 2013 | 6234 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2014 | 42232 | 0.030 |
Why?
|
| Mutation | 2 | 2015 | 30053 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 4758 | 0.030 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2012 | 55 | 0.030 |
Why?
|
| Immune System Diseases | 1 | 2014 | 256 | 0.030 |
Why?
|
| Pregnancy | 1 | 2013 | 29890 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2015 | 787 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7391 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2014 | 386 | 0.020 |
Why?
|
| Homozygote | 1 | 2015 | 1776 | 0.020 |
Why?
|
| Natural Killer T-Cells | 1 | 2013 | 322 | 0.020 |
Why?
|
| Ozone | 1 | 2013 | 483 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 1175 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Child | 2 | 2015 | 80158 | 0.020 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 366 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 638 | 0.020 |
Why?
|
| Diarrhea | 1 | 2014 | 1318 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8710 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2014 | 2118 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2015 | 1909 | 0.020 |
Why?
|
| Disease Management | 1 | 2015 | 2508 | 0.010 |
Why?
|
| Male | 4 | 2019 | 360846 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 6214 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9327 | 0.010 |
Why?
|
| Female | 4 | 2019 | 392705 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 2006 | 478 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3688 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2155 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3677 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3415 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8002 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2006 | 2612 | 0.010 |
Why?
|
| DNA Repair | 1 | 2006 | 2046 | 0.010 |
Why?
|
| DNA Damage | 1 | 2006 | 2449 | 0.010 |
Why?
|
| Animals | 3 | 2015 | 168475 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 88326 | 0.010 |
Why?
|
| Chromatin | 1 | 2006 | 2961 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 81539 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59260 | 0.010 |
Why?
|
| United States | 1 | 2019 | 72340 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9420 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14417 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80647 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10451 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 16592 | 0.000 |
Why?
|
| Aged | 1 | 2019 | 169310 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 220921 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 221210 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2006 | 23447 | 0.000 |
Why?
|
Concepts
(91)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_